Showing 3911-3920 of 21451 results for "".
- Laser Speckle Imaging Shows Promise for Objective Rosacea Assessment: Analysishttps://reachmd.com/news/laser-speckle-imaging-shows-promise-for-objective-rosacea-assessment-analysis/2487680/
- Stopping Beta Blockers After Myocardial Infarctionhttps://reachmd.com/news/stopping-beta-blockers-after-myocardial-infarction/2487597/Key Takeaways Discontinuation was noninferior to continuation for the composite outcome studied. Stable post-MI patients with a left ventricular ejection fraction of at least 40% and no heart failure were randomized after at least 1 year of therapy to
- Depemokimab Indirect Comparison Shows Similar Asthma Exacerbation Reductionhttps://reachmd.com/news/depemokimab-indirect-comparison-shows-similar-asthma-exacerbation-reduction/2487563/Key Takeaways In the fully adjusted model, depemokimab was associated with lower annualized exacerbation rates than placebo, while adjusted comparisons with other biologics were not statistically significant. Exacerbation estimates came from 17 trials
- Aglatimagene Besadenovec Plus Radiotherapy Improves Disease-Free Survivalhttps://reachmd.com/news/aglatimagene-besadenovec-plus-radiotherapy-improves-disease-free-survival/2487564/Key Takeaways Median disease-free survival was not reached with aglatimagene plus valacyclovir and was 86.1 months with placebo plus valacyclovir. The phase 3 randomized, double-blind, placebo-controlled trial enrolled 745 men across 51 centres in the
- C-TRACT Trial: Endovascular Therapy Lowers PTS Severity, Improves QOLhttps://reachmd.com/news/c-tract-endovascular-pts-severity-qol/2487536/Key Takeaways Six-month post-thrombotic syndrome severity was lower with endovascular therapy plus standard care than with standard care alone. Patient-reported quality of life was better with the endovascular strategy on both VEINES-QOL and SF-36.
- Triple Low-Dose Antihypertensive Pill After Intracerebral Hemorrhagehttps://reachmd.com/news/triple-low-dose-antihypertensive-pill-intracerebral-hemorrhage/2487533/Key Takeaways Recurrent stroke was less frequent with the fixed low-dose triple pill than with placebo during follow-up. Mean systolic blood pressure during follow-up and major cardiovascular events were lower in the triple-pill group. Serious
- Phase 2a Trial of Intrapleural LTI 01 in Pleural Infectionhttps://reachmd.com/news/phase-2a-intrapleural-lti-01-pleural-infection/2487539/Key Takeaways Overall treatment failure within 7 days was not significantly different between LTI-01 and placebo. Predetermined sensitivity analyses showed efficacy trends in the 400,000-U group, while pleural opacification changes were strongest at 80
- Text Messaging and FIT Completion in a Quality Improvement Trialhttps://reachmd.com/news/text-fit-completion-quality-improvement/2487515/Key Takeaways FIT completion within 21 days was higher in the text group than in the telephone group. Adults with new FIT orders at eight Brooklyn FQHCs were randomized 1:1 to three one-way texts on days 2, 5, and 8 or one nurse-led day-8 call.
- Analysis Shows Long-Term Cost Impact of Psoriasis and Psoriatic Arthritishttps://reachmd.com/news/analysis-highlights-long-term-cost-impact-of-psoriasis-and-psoriatic-arthritis/2487486/New research published in Dermatology and Therapy suggests the economic burden associated with psoriasis and psoriatic arthritis extends far beyond the diseases themselves and may reach hundreds of billions of dollars over a lifetime. Psoriatic Disease Comorbidities Drive Signifi
- Intramuscular Sedatives for Methamphetamine Agitation in the EDhttps://reachmd.com/news/intramuscular-sedatives-for-methamphetamine-agitation-in-the-ed/2487500/Key Takeaways Droperidol, olanzapine, and midazolam were similarly effective, while lorazepam was associated with slower sedation. Rescue medication was reported in 16% of droperidol cases, 20% of olanzapine cases, 13% of midazolam cases, and 46% of lo